| Press Release | |
Judges Scientific plc
("Judges Scientific" or the "Company")
Purchase of Ordinary Shares
Judges Scientific announces that it has today acquired 849 ordinary shares of 5p each ("Ordinary Share") at a price of 6,200p per Ordinary Share. The Ordinary Shares have been immediately allocated to certain employees to satisfy awards under the Company's reward scheme.
- Ends -
| For further information please contact:
| |
| Judges Scientific plc David Cicurel, CEO Brad Ormsby, FD
| Tel: 020 3829 6970
|
| Shore Capital (Nominated Adviser & Broker) Stephane Auton Edward Mansfield Sarah Mather
| Tel: 020 7408 4090
|
| Liberum (Joint Broker) Bidhi Bhoma Euan Brown
Alma PR (Financial Public Relations) Sam Modlin Justine James | Tel: 020 3100 2222
Tel: 020 3405 0205 |
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector . The Group consists of 19 businesses acquired since it was re-admitted to AIM in 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
